Table 2.
Patients’ characteristics.
| Characteristics | N. (%) |
|---|---|
| Age | |
| Median: 50.5 years (26–73 years) | |
| Histology | |
| Squamous cell carcinoma | 150 (92.6%) |
| Adenocarcinoma | 7 (4.3%) |
| Adenosquamous carcinoma | 3 (1.9%) |
| Others | 2 (1.2%) |
| Lymph node metastasis | |
| PLNM only | 120 (74.1%) |
| PALNM only | 4 (2.5%) |
| PLN + PALNM | 38 (23.4%) |
| FIGO stage (2018) | |
| IIIC1 | 120 (74.1%) |
| IIIC2 | 42 (25.9%) |
| Radiation dose of LNM | |
| Median: 60.2 Gy | |
| ≥60 Gy | 121 (74.7%) |
| <60 Gy | 41 (25.3%) |
| Cycles of concurrent chemotherapy | |
| 0 | 8 (4.9%) |
| 1–3 | 17 (10.5%) |
| ≥4 | 137 (84.6%) |
| Total | 162 (100%) |
Notes: PLNM = pelvic lymph node metastasis; PALNM = para-aortic lymph node metastasis.